Gene · 9869
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases. | Mol Cells | 2021 | 34963103 | PubTator, text mining | PubMed |
| Comprehensive Profiling of Mammalian Tribbles Interactomes Implicates TRIB3 in Gene Repression. | Cancers (Basel) | 2021 | 34944947 | PubTator, text mining | PubMed |
| Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers. | Cancers (Basel) | 2021 | 34944799 | PubTator, text mining | PubMed |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| Aspects of the Epigenetic Regulation of EMT Related to Cancer Metastasis. | Cells | 2021 | 34943943 | PubTator, text mining | PubMed |
| Epigenetic modifications of tumor necrosis factor-alpha in joint cartilage tissue from osteoarthritis patients - CONSORT. | Medicine (Baltimore) | 2021 | 34941032 | PubTator, text mining | PubMed |
| Research progress in hepatitis B virus covalently closed circular DNA. | Cancer Biol Med | 2021 | 34931766 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. | Mol Cancer | 2021 | 34930302 | PubTator, text mining | PubMed |
| Signal pathways of melanoma and targeted therapy. | Signal Transduct Target Ther | 2021 | 34924562 | PubTator, text mining | PubMed |
| Malignant pleural mesothelioma: an update. | J Bras Pneumol | 2021 | 34909922 | PubTator, text mining | PubMed |
| Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases. | Curr Res Pharmacol Drug Discov | 2021 | 34909644 | PubTator, text mining | PubMed |
| Using epigenetic modifiers to target cancer stem cell immunoevasion. | Cancer Cell | 2021 | 34906316 | PubTator, text mining | PubMed |
| Neuron-specific chromosomal megadomain organization is adaptive to recent retrotransposon expansions. | Nat Commun | 2021 | 34903713 | PubTator, text mining | PubMed |
| Trim28 acts as restriction factor of prototype foamy virus replication by modulating H3K9me3 marks and destabilizing the viral transactivator Tas. | Retrovirology | 2021 | 34903241 | PubTator, text mining | PubMed |
| Crosstalk Between Inflammatory Signaling and Methylation in Cancer. | Front Cell Dev Biol | 2021 | 34901003 | PubTator, text mining | PubMed |
| Emerging role of m6A methylation modification in ovarian cancer. | Cancer Cell Int | 2021 | 34895230 | PubTator, text mining | PubMed |
| Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. | Front Pharmacol | 2021 | 34887768 | PubTator, text mining | PubMed |
| Genome Instability in Multiple Myeloma: Facts and Factors. | Cancers (Basel) | 2021 | 34885058 | PubTator, text mining | PubMed |
| Misregulation of the expression and activity of DNA methyltransferases in cancer. | NAR Cancer | 2021 | 34870206 | PubTator, text mining | PubMed |
| Collateral Victim or Rescue Worker?-The Role of Histone Methyltransferases in DNA Damage Repair and Their Targeting for Therapeutic Opportunities in Cancer. | Front Cell Dev Biol | 2021 | 34869318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9869/papers?page=42